Ramucirumab
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-P9920-1 mg |
| CAS # | 947687-13-0 |
| Pricing | 1 mg, USD $400.0 |
| Biological Activity | Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors[1]. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF-A, VEGF-C, and VEGF-D[2]. |
| Purity | 99.40% |
| MWt | 6369.07 |
| Formula | C₂₈₅H₄₃₄N₇₄O₈₈S₂ |